The Five Survivors — Stocks That Cleared Iggys' Q2 2026 Screener |🦖EP1533

The Investing Iguana
04-08 19:50

The Five Survivors — Stocks That Cleared Iggys' Q2 2026 Screener |🦖EP1533

The STI is at 5,000 and the crowd is chasing yields — but only five SGX stocks survived my ruthless Q2 2026 forensic audit of gearing, ICR, Altman Z-Score, and a stress-tested dividend floor. One trust pays 7.7% with 39.6% gearing under a Business Trust framework, another sits 41% below InvestingPro Fair Value, and a third just crossed S$5 billion in revenue for the first time — yet the market is still sleeping on all three.

In a post-5,000 STI, the 1.46% T-Bill tells you complacency is the default. My 3.2% forensic floor and 4.7% absolute yield hurdle exist precisely because calm weather is when balance sheet rot goes undetected. Every name in this cohort was screened to protect S$100,000 of retirement capital first — the yield is the reward for surviving the audit, not the reason to enter.

📺 YouTube: https://youtu.be/lalPYh-nRdI

📩 Substack: https://investingiguana.com/p/the-five-survivors-stocks-that-cleared

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment